Bunkport – Liquidity Meets Performance A Proprietary Hedge Fund Strategy
Join the Family Office Networks’ Webinar Series featuring Bunkport Partners LP.
Bunkport Partners LP is a US equity focused opportunistic investment strategy designed to deliver superior performance, through meaningfully participating in the market’s strongest stocks, while also avoiding the severe equity market drawdowns. They have a 20% annual net return target with a low correlation to the major equity markets or any specific investment style.
Bunkport endeavors to generate a private equity return profile with a public equity liquidity profile.
PSY Therapeutics – Mental Health is in Crisis
Join the Family Office Networks’ Webinar Series featuring Psy Therapeutics, Inc.
Psy Therapeutics, Inc. is an emerging biopharmaceutical company focused on developing transformative medicines to treat serious neuropsychiatric disorders. The Company’s novel approach to customized small molecule drug discovery and development combines cutting-edge technology with an extensive network of collaborators to drive R&D innovation and productivity.
Mental illness and neurodegenerative disorders continue to wreak havoc on patients, their families, and our society.
Introduction: tZERO Overview
Presentation Led by tZERO’s Business Development & Capital Markets Team
Panel Discussion: ‘Advantages of Enabling Liquidity of Private Assets’
Discussion with Panelists:
Michael Gaviser, Former KKR Managing Director
Alan Konevsky, tZERO Chief Legal Officer
Hubertus Thonhauser, Tezos Foundation Council Chair Member
Keynote Presentation: ‘The Future of Investments & Trading’
Keynote Led by John Jacobs, Former Nasdaq EVP
Join the Family Office Networks’ Webinar Series to learn more about tZERO, a leader in financial innovation and liquidity for private companies. tZERO Group, Inc. and its broker-dealer subsidiaries (tZERO) offers institutional-grade solutions for issuers looking to digitize their capital table and trade on a regulated alternative trading system. tZERO democratizes access to private assets by providing a simple, automated, and efficient trading venue to broker-dealers, institutions, and investors. TRAC is a new kind of quantitative early-stage venture firm. The unique predictive technology combines superhuman forecasters and machine intelligence to accurately predict future unicorns early and with an overall accuracy 60%.
tZero – Enabling Private Market Liquidity Through Digital Securities
Join the Family Office Networks’ Webinar Series to learn more about tZERO, a leader in financial innovation and liquidity for private companies. The webinar will include the following:
Introduction: tZERO Overview
Presentation Led by tZERO’s Business Development & Capital Markets Team
Panel Discussion: ‘Advantages of Enabling Liquidity of Private Assets’
Discussion with Panelists:
Michael Gaviser, Former KKR Managing Director
Alan Konevsky, tZERO Chief Legal Officer
Hubertus Thonhauser, Tezos Foundation Council Chair Member
Keynote Presentation: ‘The Future of Investments & Trading’
Keynote Led by John Jacobs, Former Nasdaq EVP
Join the Family Office Networks’ Webinar Series to learn more about tZERO, a leader in financial innovation and liquidity for private companies. tZERO Group, Inc. and its broker-dealer subsidiaries (tZERO) offers institutional-grade solutions for issuers looking to digitize their capital table and trade on a regulated alternative trading system. tZERO democratizes access to private assets by providing a simple, automated, and efficient trading venue to broker-dealers, institutions, and investors. TRAC is a new kind of quantitative early-stage venture firm. The unique predictive technology combines superhuman forecasters and machine intelligence to accurately predict future unicorns early and with an overall accuracy 60%.
TRAC – How to Find and Buy the Next Amazon
Join the Family Office Networks Webinar Series Featuring Trac Unicorn Fund “A Quantitative Venture Firm Investing in Future Unicorns”.
TRAC is a new kind of quantitative early-stage venture firm. The unique predictive technology combines superhuman forecasters and machine intelligence to accurately predict future unicorns early and with an overall accuracy 60%.
Innovative Medicine Partners – A Better Fertility Solution
Join the Family Office Networks Webinar Series Featuring Innovative Medicine Partners (IMP).
Innovative Medicine Partners (IMP) is a dynamic network of medical visionaries working in collaboration to develop novel medical procedures and devices. Our expert team of clinicians, scientists, engineers, legal advisors, regulatory specialists, marketing experts, and financial professionals possesses an unparalleled level of experience in all aspects required to bring medical devices from concept to commercialization.
Emerald Park Capital – Thinking Green in Cannabis, Debt Strategy & Growth Industry
Emerald Park Capital (EPC) is an emerging manager actively providing capital to the legal cannabis industry – Currently raising flagship fund of up to $110 million.
Current market factors combined with positive industry dynamics present investors with excellent investment opportunities and risk adjusted returns
Despite COVID-19, the cannabis industry has been deemed essential and continues to grow
Typical investments include senior secured debt facilities and structured equity –Utilizing a combination of current yield and equity kickers – Strong enterprise level credit support provided by top tier borrowers
EPC has built a team of seasoned investors and partners who have worked together on numerous deals over the past 10+ years, with a combined cannabis experience of 60+ completed transactions – Infrastructure support provided by EPC’s affiliate, Bryant Park Capital, a middle market investment bank that has advised in >300 closed transactions, representing >$30 billion in value
AltaThera Pharmaceuticals – Growth Capital for Commercial Expansion of FDA-Approved Drug
Come join the Family Office Networks’ Webinar Series featuring AltaThera Pharmaceuticals. AltaThera Pharmaceuticals is a commercial stage hospital-focused pharmaceutical company applying innovative science to address unmet medical needs while reducing healthcare costs. AltaThera is committed to providing therapies that increase efficient treatment of the complex challenges of atrial fibrillation (AFib), a serious and costly health problem.
AIRAM – Life Settlement Longevity-Based Investing
Join the Family Office Networks Webinar Series Featuring AIR Asset Management. AIRAM advises and manages investment vehicles that provide unique opportunities within the alternative investment space to qualified investors. AIRAM focuses on life settlements and other longevity-linked investment products.
Richard Beleutz, Chief Executive Officer and Scott Romanek, Managing Director of Sales & Marketing will discuss how they leverage the proficiency and experience of an extensive network of strategic partners to deploy investment strategies.
Soligenix, Inc – Superlative Performance in Rare Diseases
Join the Family Office Networks’ Webinar Series featuring Soligenix, Inc.
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.
The Focus:
A Specialized BioTherapeutics business segment dedicated to the development of products for orphan diseases and areas of unmet medical need in oncology and inflammation.
A Public Health Solutions business segment, funded entirely by the US Government to the amount of approximately $70 million to date, developing vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, emerging and antibiotic resistant infectious disease, and viral disease including Ebola, Marburg and COVID-19.
Nasdaq: SNGX Stock Snapshot as of 10/01/20 Market Cap: ~ $53.7 Million Stock Price: $1.80 Avg Daily Vol (50D): ~ 1.1M Shares Outstanding: ~ 29.8 Million
IQEQ – Tech-Enabled Portfolio Monitoring Strategies For Investors
Join the Family Office Networks’ Webinar Series featuring IQ-EQ.
IQ-EQ will tell you it is now more important than ever before to identify the right analytical tools and data that can help investors in assessing their investment decisions. Indeed, without fresh information, processed at the speed at which markets are moving, investment professionals could be operating sub-optimally—at a critical time.
IQ-EQ believes that some investors may need to consider how to reposition investment portfolios to navigate through these turbulent times with the right long-term objectives in mind. In this context, integrating ESG data capture into your portfolio reporting strategies could be an essential element of your long-term investment strategy.